Table 2 The difference in median progression-free survival (PFS) is based on a given biomarker.

From: High WEE1 expression is independently linked to poor survival in multiple myeloma

Feature name

WEE1-high PFS (years)

WEE1-low PFS (years)

Hyperdiploidy

1.838

2.685

t(4;14)

1.115

2.436

t(11;14)

ND

1.956

MAF translocation

ND

1.921

MYC translocation

2.121

2.436

Chromothripsis

2.427

2.427

Hyper APOBEC

2.378

1.942

TP53 deletion

ND

1.608

  1. “Positive” indicates the cohort which has the listed feature. “Negative” indicates the cohort which does not have the listed feature. The difference is calculated as the median PFS of the WEE1-low group minus the median PFS of the WEE1-high group. ND is defined as “no data” and indicates that the LR group did not reach the median PFS mark.